[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100450773":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":28,"locations":38,"responsibleParty":63,"collaborators":65,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":10,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Laval University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"BED+ : Participants with obesity and binge eating disorder",null,"Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 positive score and a Binge Eating Scale score \\>16",[13],"Other: Observational",{"label":15,"type":10,"description":16,"interventionNames":17},"BED-: Participants with obesity but without binge eating disorder","Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 negative score and a Binge Eating Scale score \\\u003C 12",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Observational","(no intervention)",[9,15],[24],{"name":25,"affiliation":26,"role":27},"Sylvain Iceta","Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","PRINCIPAL_INVESTIGATOR",[29,35],{"name":30,"role":31,"phone":32,"phoneExt":33,"email":34},"Sylvain Iceta, MD, PhD","CONTACT","+1 (418) 656-8711","4565","equipe.iceta@criucpq.ulaval.ca",{"name":36,"role":31,"phone":32,"phoneExt":37,"email":34},"Pelletier Melissa","2136",[39,54],{"facility":40,"status":41,"city":42,"state":10,"zip":10,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Centre d'expertise Poids, Image et Alimentation (CEPIA)","NOT_YET_RECRUITING","Québec","Canada","CA",{"type":46,"coordinates":47},"Point",[48,49],-71.21454,46.81228,{"lat":49,"lon":48},[52],{"name":53,"role":31,"phone":10,"phoneExt":10,"email":10},"Catherine Bégin, PhD",{"facility":55,"status":56,"city":42,"state":10,"zip":10,"country":43,"countryCode":44,"cosmosGeoPoint":57,"geoPoint":59,"contacts":60},"IUCPQ","RECRUITING",{"type":46,"coordinates":58},[48,49],{"lat":49,"lon":48},[61],{"name":62,"role":31,"phone":10,"phoneExt":10,"email":10},"sylvain Iceta",{"type":27,"investigatorFullName":25,"investigatorTitle":64,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Principal Investigator",[66,67],{"name":26,"class":6},{"name":40,"class":68},"UNKNOWN","100450773","compuls-bed-severity-100450773",false,"NCT05149859","Compuls-BED-Severity","Reconsidering Severity Classification for Binge Eating Disorder (BED): the Role of Impulsivity, Compulsivity and Co-occurring Disorders","Inclusion Criteria:\n\n* men or women aged 1\n* participants eligible for bariatric surgery (BMI\\>40, or BMI\\>35 with severe comorbidities)\n* participants scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic (BMI≥30)\n* participants scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI≥30)\n* for the group with BED: positive BEDS-7 screen and Binge Eating Scale score \\>16;\n* for the control group: have a negative BEDS-7 screen and Binge Eating Scale score\\\u003C12\n* be fluent in French and able to consent.\n\nExclusion criteria :\n\n* participants with severe neurological disorder and\u002For major neurocognitive deficits;\n* participants with previous bariatric surgery or with introduction or change of anti-obesity medication (liraglutide or naltrexone\u002Fbupropion) in the previous 3 months;\n* participants who cannot read and\u002For understand French;\n* participants under guardianship or curatorship;\n* participants already included in a study with a conflict of interest with this study;\n* inability to use a computer or iPad;\n* inability to access an Internet connection or to visit one of the inclusion sites.\n\nSecondary exclusion criteria:\n\n* participants with a discordance between BEDS-7 (positive) and Binge Eating Scale (score ≤ 16) results found secondarily\n* participants who did not participate in part of the assessments (e.g., self-questionnaires or neurocognitive tests) and participants with a rate of missing data\\>10%.","ALL","18 Years","65 Years",{"count":80,"type":81},200,"ESTIMATED","OBSERVATIONAL","* Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established.\n* Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity.\n* Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care.\n\nThe investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).",[85],"Binge-Eating Disorder",[85,87,88,89,90],"Impulsivity","Obesity","Attention","Emotional regulation","2024-10-07",{"date":93,"type":94},"2024-10-09","ACTUAL",{"date":96,"type":94},"2023-03-07",{"date":98,"type":81},"2025-12-31",{"name":5,"class":6},2]